- Filed
- Mar 31, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Mar 26, 2021 | 39.9M sh |
| Shares Diluted | FY 2020 · Dec 31, 2020 | 39.46M sh |
| Shares Diluted | FY 2020 · Dec 31, 2019 | 39.09M sh |
| Capex | FY 2020 · Dec 31, 2020 | $3.05M |
| Capex | FY 2020 · Dec 31, 2019 | $3.77M |
| Operating Cash Flow | FY 2020 · Dec 31, 2020 | $1.04M |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | $2.46M |
| Cash And Equivalents | FY 2020 · Dec 31, 2020 | $5.75M |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $10.97M |
| Stockholders Equity | FY 2020 · Dec 31, 2020 | $33.48M |
| Stockholders Equity | FY 2020 · Dec 31, 2019 | $43.66M |
| Stockholders Equity | FY 2020 · Dec 31, 2018 | $51.17M |
| Current Liabilities | FY 2020 · Dec 31, 2020 | $24.53M |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $29.66M |
| Total Liabilities | FY 2020 · Dec 31, 2020 | $29.77M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $36.21M |
| Current Assets | FY 2020 · Dec 31, 2020 | $26.36M |
| Current Assets | FY 2020 · Dec 31, 2019 | $34.49M |
| Total Assets | FY 2020 · Dec 31, 2020 | $63.24M |
| Total Assets | FY 2020 · Dec 31, 2019 | $79.88M |
| Eps Diluted | FY 2020 · Dec 31, 2020 | −$0.29 |
| Eps Diluted | FY 2020 · Dec 31, 2019 | −$0.23 |
| Eps Basic | FY 2020 · Dec 31, 2020 | −$0.29 |
| Eps Basic | FY 2020 · Dec 31, 2019 | −$0.23 |
| Sga Expense | FY 2020 · Dec 31, 2020 | $14.36M |
| Sga Expense | FY 2020 · Dec 31, 2019 | $17.73M |
| Rd Expense | FY 2020 · Dec 31, 2020 | $12.01M |
| Rd Expense | FY 2020 · Dec 31, 2019 | $18.27M |
| Net Income | FY 2020 · Dec 31, 2020 | −$11.56M |
| Net Income | FY 2020 · Dec 31, 2019 | −$9.02M |
| Operating Income | FY 2020 · Dec 31, 2020 | −$10.66M |
| Operating Income | FY 2020 · Dec 31, 2019 | −$7.81M |
| Revenue | FY 2020 · Dec 31, 2020 | $81.36M |
| Revenue | FY 2020 · Dec 31, 2019 | $121.85M |